Cardiac ganglion catheter ablation to treat significant bradycardia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This combined basic and clinical program uses standardized catheter ablation targeting cardiac ganglionated plexi to suppress excessive vagal signaling that contributes to symptomatic bradycardia. Participants undergo the ablation procedure or a sham control under a controlled protocol, with predefined safety and efficacy endpoints including heart rate changes and symptom recurrence. Parallel mechanistic basic-research work is integrated to improve understanding of how ganglion ablation alters autonomic control of the heart. The study emphasizes reproducible procedures and rigorous follow-up to establish both clinical effect and safety.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age range: 18 - 65 years old
2. Have symptoms related to bradycardia (syncope, dizziness, blackout, palpitations, fatigue, listlessness, inability to concentrate and decreased activity endurance, etc.)
3. Meet one of the following conditions: ①Dynamic electrocardiogram shows an average heart rate of less than 50 beats per minute or there is a heart arrest lasting more than 3 seconds during the day; ②Transient second or third degree atrioventricular conduction block without hemodynamic disorders during the day
4. The atropine test showed that the sinus heart rate increased by ≥ 25%, or the heart rate was ≥ 90 beats per minute, or the atrioventricular conduction block was significantly improved to be no more than first-degree atrioventricular conduction block.

Exclusion Criteria:

1. A history of severe trauma caused by bradycardia
2. Regular use of antiarrhythmic drugs within the past 3 months
3. Prior implantation of a cardiac pacemaker
4. Existing implantation of, or indication for implantation of, electronic devices with pacing function, such as cardiac contractility modulators (CCMs), implantable cardioverter-defibrillators (ICDs), or cardiac resynchronization therapy (CRT) devices
5. Bradycardia or atrioventricular block caused by medications or other reversible factors (e.g., hyperkalemia, hypothyroidism)
6. Bradycardia or atrioventricular block associated with obstructive sleep apnea syndrome (OSAS)
7. Coronary revascularization within the past 3 months, or unstable coronary heart disease despite standardized medical treatment or revascularization
8. Stroke or transient ischemic attack (TIA) within the past 3 months
9. A history of open-heart surgery
10. Severe congenital heart disease
11. Complicated with severe ventricular arrhythmia
12. Severe cardiac insufficiency with left ventricular ejection fraction (LVEF) ≤ 35%
13. Severe cardiomyopathy, such as hypertrophic obstructive cardiomyopathy (HOCM), dilated cardiomyopathy (DCM), or cardiac amyloidosis
14. Severe aortic or mitral valve stenosis
15. Pregnancy or lactation period
16. Expected survival time of less than 1 year
17. Refusal to sign the informed consent form
18. Other conditions deemed ineligible by the researchers

Where it's running

• Beijing Anzhen Hospital, Capital Medical University
  Beijing, China, China Recruiting

Study contacts

• Principal investigator: Ning Zhou — Beijing Anzhen Hospital
• Study coordinator: Liu He, PhD.
• Email: theliu@139.com
• Phone: +86 138-1072-0787

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Structured Combined Exercise Program for Postmenopausal Women

  This trial tests whether a guided 12-week exercise program can improve heart health, menopausal symptoms, sleep, and quality of life in women aged 45–65 who are postmenopausal.

  Recruiting Fenerbahce University · Istanbul, Atasehir · NCT07615790

• Polish registry of heart nerve–targeting treatments (cardioneuroablation and cardioneuromodulation)

  This registry collects information to see how nerve-targeting heart procedures work for adults with fainting, abnormal heart rhythms, or orthostatic problems.

  Recruiting SABAMED Medical Center Ltd. · Rzeszów · NCT07196397

• Mandibular stretching and 4-4-8 breathing for autonomic nervous system activity

  This will test whether jaw-stretching and 4-4-8 breathing change nervous system activity, muscle tension, and psychological state in healthy university students.

  Recruiting Necmettin Erbakan University · Konya, Konya · NCT07472010

• Nerve and heart activity in hepatocellular carcinoma (HCC)

  This project will test whether measuring autonomic nervous system signals—such as heart rate patterns, sensory‑response tests, and liver biopsy markers—can help detect or better characterize HCC in adults with compensated cirrhosis who are having a liver biopsy.

  Recruiting Hospices Civils de Lyon · Lyon · NCT07393074

• Evaluating cardiovascular and cerebrovascular control in healthy individuals

  This study tests how well the heart and brain work together in healthy people by looking at their responses to changes in position.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Milan · NCT05706532

• Ear (auricular) vagus nerve stimulation to see if a short session changes breathing test results

  This will test whether a brief, non-invasive electrical stimulation of the outer ear changes spirometry (breathing) measurements in healthy adults aged 18–40.

  Recruiting Sinop University · Sinop · NCT07482930

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.